Your browser doesn't support javascript.
loading
Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
Magnusson, Lisa U; Hagberg Thulin, Malin; Plas, Pascale; Olsson, Anders; Damber, Jan-Erik; Welén, Karin.
Affiliation
  • Magnusson LU; Sahlgrenska Cancer Center, Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Hagberg Thulin M; Sahlgrenska Cancer Center, Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Plas P; IPSEN Oncology and Biomarkers, Les Ulis, France.
  • Olsson A; Active Biotech AB, Lund, Sweden.
  • Damber JE; Sahlgrenska Cancer Center, Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Welén K; Sahlgrenska Cancer Center, Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Prostate ; 76(4): 383-93, 2016 Mar.
Article in En | MEDLINE | ID: mdl-26660725
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Quinolines / Bone Neoplasms / Tumor Microenvironment / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Prostate Year: 2016 Document type: Article Affiliation country: Sweden Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Quinolines / Bone Neoplasms / Tumor Microenvironment / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Prostate Year: 2016 Document type: Article Affiliation country: Sweden Country of publication: United States